Science Explorer Back to mapMap
Discussion
Researcher · SocraTec R&D (Germany) · Germany

Meinolf Wonnemann

Meinolf Wonnemann publishes mostly in Plant Science, Pharmacology and Pharmaceutical Science, on topics such as Natural Compound Pharmacology Studies, Drug Solubulity and Delivery Systems and Pharmaceutical studies and practices.

ORCID 0000-0002-3200-6867 OpenAlex
World rank
#1,924,815
of 7,710,434 ranked researchers
Rank in Germany
#95,021
of 364,343
Works
33
Citations
1.7k
Citations per work
51.1
h-index
17
i10-index 19Top 23% in Plant Science
Meinolf Wonnemann

What does Meinolf Wonnemann research?

Meinolf Wonnemann's work is mostly in Medicine (22%), Pharmacology, Toxicology and Pharmaceutics (14%), Agricultural and Biological Sciences (10%).

Everything else: 18 works · 53.8% of their workLife Sciences: 8 works · 24.2% of their workPharmacology, Toxicology and Pharmaceutics: 5 works · 14.3% of their workPharmaceutical Science: 3 works · 7.7% of their workPharmacology: 2 works · 6.6% of their workAgricultural and Biological Sciences: 3 works · 9.9% of their workPlant Science: 3 works · 9.9% of their workHealth Sciences: 7 works · 22.0% of their workMedicine: 7 works · 22.0% of their workPharmacology: 3 works · 8.8% of their workComplementary and alternative medicine: 2 works · 6.6% of their workEpidemiology: 2 works · 6.6% of their workTHEIR WORKMeinolf Wonnemann33works
Life Sciences24%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1853.8%
    1. Pharmacology, Toxicology and Pharmaceutics514.3%
    2. Agricultural and Biological Sciences39.9%
    1. Medicine722.0%
  1. 1Plant Science10% of their works
  2. 2Pharmacology9% of their works
  3. 3Pharmaceutical Science8% of their works
  4. 4Epidemiology7% of their works
  5. 5Pharmacology7% of their works
  6. 6Complementary and alternative medicine7% of their works

Research topics

Which keywords describe Meinolf Wonnemann's research?

The keywords of their largest research topics: Antioxidant, Cyclodextrins, Garcinia Mangostana, Solid Dispersions, St John's Wort, Treatment Guidelines, Off-Label Drug Use and Pediatric Pharmacokinetics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Antioxidant92 topics
  2. Cyclodextrins61 topic
  3. Garcinia Mangostana61 topic
  4. Solid Dispersions61 topic
  5. St John's Wort61 topic
  6. Treatment Guidelines62 topics
  7. Off-Label Drug Use51 topic
  8. Pediatric Pharmacokinetics51 topic
  9. Chronic Cough41 topic
  10. Cough Reflex Sensitivity41 topic
  11. Chronic Rhinosinusitis31 topic
  12. Dendrobium31 topic
  13. Epidemiology31 topic
  14. Gastrodia31 topic
  15. Green Analytical Chemistry31 topic
  16. Nasal Polyps31 topic
  17. Pharmaceutical Analysis31 topic
  18. Urinary Tract Infections31 topic

Where does Meinolf Wonnemann work?

Meinolf Wonnemann's main affiliation in the publication record is SocraTec R&D (Germany), Germany.

How many publications and citations does Meinolf Wonnemann have?

OpenAlex counts 33 works and 1,687 citations for Meinolf Wonnemann, an h-index of 17, ranking #1,924,815 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Meinolf Wonnemann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.